GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash and Bank History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹1,391 Cr | ₹1,404 Cr | ₹1,063 Cr | ₹1,156 Cr | ₹2,485 Cr |
What is the latest Cash and Bank ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Cash and Bank |
|---|---|
| Mar2026 | ₹1,391 Cr |
| Mar2025 | ₹1,404 Cr |
| Mar2024 | ₹1,063 Cr |
| Mar2023 | ₹1,156 Cr |
| Mar2022 | ₹2,485 Cr |
How is Cash and Bank of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,391 Cr | -0.89 | |
| Mar2025 | ₹1,404 Cr | 32.01 | |
| Mar2024 | ₹1,063 Cr | -8.02 | |
| Mar2023 | ₹1,156 Cr | -53.47 | |
| Mar2022 | ₹2,485 Cr | - | |
Compare Cash and Bank of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,902.2 Cr | 3.1% | -7.3% | -4.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,122.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,424.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,914.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,599.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹113,112.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 3.1% |
-7.3% |
-4.9% |
| SENSEX | 5.5% |
7.5% |
-8.7% |
You may also like the below Video Courses